Konstantinos Stavroulakis
A5020994480- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Aortic aneurysm repair treatments
- Venous Thromboembolism Diagnosis and Management
- Cardiac, Anesthesia and Surgical Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Aortic Disease and Treatment Approaches
- Coronary Interventions and Diagnostics
- Acute Ischemic Stroke Management
- Diagnosis and Treatment of Venous Diseases
- Diabetic Foot Ulcer Assessment and Management
- Central Venous Catheters and Hemodialysis
- Renal and Vascular Pathologies
- Infectious Aortic and Vascular Conditions
- Lipoproteins and Cardiovascular Health
- Cardiac Valve Diseases and Treatments
- Vascular anomalies and interventions
- Antiplatelet Therapy and Cardiovascular Diseases
- Abdominal vascular conditions and treatments
- Surgical Simulation and Training
- Bariatric Surgery and Outcomes
- Workplace Violence and Bullying
- Innovations in Medical Education
- Simulation-Based Education in Healthcare
- Kidney Stones and Urolithiasis Treatments
Ludwig-Maximilians-Universität München
2020-2025
LMU Klinikum
2022-2025
Klinikum Arnsberg
2025
Klinikum Rheine
2024-2025
University of Augsburg
2023
University of Jaffna
2023
St. Franziskus Hospital
2014-2022
University Hospital Münster
2014-2022
University of Münster
2015-2020
University Hospital of Heraklion
2016-2017
A clear patency benefit of a drug-eluting stent (DES) over bare metal stents (BMSs) for treating peripheral artery disease the femoropopliteal segment has not been definitively demonstrated. The EMINENT study (Trial Comparing Eluvia Versus Bare Metal Stent in Treatment Superficial Femoral and/or Proximal Popliteal Artery) was designed to evaluate DES (Boston Scientific, Marlborough, MA), polymer-coated paclitaxel-eluting stent, compared with BMSs treatment lesions.EMINENT is prospective,...
While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. The objective of this analysis was to evaluate the burden regions and countries 2019 its difference 2010.
Purpose: To report a single-center study comparing drug-coated balloon (DCB) angioplasty vs directional atherectomy with antirestenotic therapy (DAART) for isolated lesions of the popliteal artery. Methods: Seventy-two patients were treated either DCB alone (n=31) or DAART (n=41) artery stenotic disease between October 2009 and December 2015. The majority presented lifestyle-limiting claudication (74% 86%, respectively). Vessel calcification (29% 29%, respectively), mean lesion length (47 42...
The Society for Vascular Surgery Lower Extremity Guidelines Committee developed the Wound, Ischemia, foot Infection (WIfI) a classification system to predict amputation risk in patients with critical limb ischemia (CLI). A number of published studies have already evaluated its prognostic value. However, most included were diabetic, and validation was done independent revascularization procedure. This single-center study value WIfI stages nondiabetic treated by endovascular means.A...
To report the 36-month outcomes from prospective, multicenter, single-arm IN.PACT Global Study (
Background: This study aimed to assess the peri- and postprocedural outcomes of atherectomy-assisted endovascular treatment common femoral (CFA) popliteal arteries. Methods: Phoenix atherectomy was used for 73 53 de novo CFA artery lesions, respectively, in 122 consecutive patients. Safety endpoints encompassed perforation peripheral embolization. Postprocedural included freedom from clinically driven target lesion revascularization (CD-TLR) clinical success (an improvement ⩾ 2 Rutherford...
Purpose: To report an experience using directional atherectomy (DA) with antirestenotic therapy (DAART) in the form of drug-coated balloon (DCB) angioplasty vs DCB alone common femoral artery (CFA) occlusive lesions. Methods: A retrospective review was conducted 47 consecutive patients (mean age 71 years; 26 men) treated between October 2011 and July 2016 either (n=26) or DAART (n=21) for CFA The majority had lifestyle-limiting claudication (14 15 DAART). Mean lesion length (39±14 mm 34±16...
To evaluate the use of a brachial artery access for endovascular treatment iliac disease.A retrospective review was conducted 201 patients (mean age 73 years; 147 men) treated via stenosis. The majority (n=141, 70%) presented with lifestyle-limiting claudication (Rutherford category 3), whereas incidence critical limb ischemia categories 4-6) 30% (n=70). Diagnostic angiography revealed TransAtlantic Inter-Society Consensus II (TASC) C/D lesion in 114 (57%) patients. primary outcome technical...
Purpose: To examine the outcomes of all first-line strategies for treatment critical limb ischemia (CLI), identify factors that influenced choice, and determine risk amputation or death after each treatment. Methods: CRITISCH ( ClinicalTrials.gov identifier NCT01877252) is a multicenter, national, prospective registry evaluating available applied in 1200 consecutive CLI patients 27 vascular centers Germany. The recruitment started January 2013 was completed September 2014. Treatment options...
The combination of intravascular lithotripsy (IVL) and drug-coated balloon (DCB) angioplasty for calcified peripheral lesions is associated with promising short-term results. However, data regarding the 12 months performance this treatment option missing. This study reports on outcomes IVL DCB femoropopliteal disease.Patients treated between February 2017 September 2020 were included into study. primary outcome measure analysis was patency. Secondary patency, freedom from target lesion...
To evaluate the midterm results of combined directional atherectomy (DA) and drug-eluting balloon (DEB) angioplasty for atherosclerotic lesions popliteal artery.In a single-arm, prospective study, 21 patients (mean age 63±16 years; 16 men) with isolated artery were enrolled underwent treatment DA DEB under filter protection between October 2009 February 2014. The majority (18, 86%) presented lifestyle-limiting intermittent claudication 3 critical limb ischemia. Fifteen (71%) target sites de...
The evaluation of arterial plaque morphology and vessel diameter is a vital component peripheral vascular interventions. Historically, digital subtraction angiography (DSA) has been considered the gold standard for sizing treatment. However, this modality limitation providing two-dimensional image three-dimensional luminal structure. Utilization intravascular ultrasound (IVUS) incorporated into diagnostic treatment algorithms to further characterize vessel. This study compared visual...
Broadly available digital and mobile health applications (also known as mHealth) have recently gained increasing attention by the vascular community, but very little is about dissemination acceptance of such technologies in certain target populations. The current study aimed to determine user behaviour amongst patients with peripheral arterial disease (PAD).A cross-sectional survey consecutively treated inpatients at 12 university institutions, well one non-university institution, was...
Abstract Purpose To investigate the long-term results of Eluvia drug-eluting stent (DES) implantation for femoropopliteal arterial disease, including ‘halo’ phenomenon. Long-term data DES is scarce. A focal reaction (‘halo’) following deployment has been described. However, clinical impact this phenomenon remains unclear. Methods This prospective, non-randomized, single-arm study included 130 consecutive patients treated with an symptomatic disease between March 2016 and December 2018....
Background: Surgical endarterectomy is currently considered the front-line therapy for treatment of calcified lesions in common femoral artery (CFA). Endovascular interventions have evolved, and their use increasing frequency. Intravascular lithotripsy (IVL) has shown promising safety effectiveness CFA a small pilot study, but “real-world” evidence from larger cohort lacking. Methods: The Disrupt PAD III Observational Study (NCT02923193) was prospective, multicenter registry designed to...